Cases & Deals

Fonds InnoBio acts as selling shareholder in reverse merger of Millendo Therapeutics with OvaScience

Client(s) BPI France (Banque Publique d'Investissement)

Jones Day advised Fonds InnoBio, managed by Bpifrance, in connection with the reverse merger of Millendo Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, with OvaScience, Inc. in an all-stock transaction, and concurrent equity financing.